Related Experiment Video
Updated: Sep 8, 2025
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
19.4K
Immune-Mediated Chronic Hepatitis in Dogs
Tarini Ullal1, Sarah Shropshire2
1Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, One Garrod Drive, Davis, CA 95616, USA.
The Veterinary Clinics of North America. Small Animal Practice
|September 5, 2025
Summary
Immune-mediated chronic hepatitis in dogs presents subtly, often diagnosed by excluding other causes and identifying interface hepatitis. Early immunosuppressive treatment offers the best prognosis for canine hepatitis.
Area of Science:
- Veterinary Internal Medicine
- Canine Hepatology
- Immunopathology
Background:
- Immune-mediated chronic hepatitis is a frequent cause of chronic liver disease in dogs.
- Clinical signs, lab results, and imaging are often non-specific, with many dogs being subclinical early on.
- Diagnosis requires excluding other liver etiologies and recognizing specific histopathologic findings.
Purpose of the Study:
- To review the diagnostic approach to immune-mediated chronic hepatitis in dogs.
- To discuss current treatment strategies and their associated adverse effects.
- To emphasize the importance of early diagnosis and intervention for optimal outcomes.
Main Methods:
- Diagnostic workup involves exclusion of differential diagnoses such as copper toxicosis, drug/toxin exposure, infections, and neoplasia.
- Histopathologic examination is crucial, with interface hepatitis being a key feature.
- Treatment typically involves immunosuppressive agents like cyclosporine, mycophenolate, or corticosteroids.
Main Results:
- Variable clinical presentations and non-specific diagnostic findings complicate early disease recognition.
- Interface hepatitis on liver biopsy is a hallmark of immune-mediated chronic hepatitis.
- Immunosuppressive therapy is the cornerstone of treatment, requiring careful consideration of side effects.
Conclusions:
- Early diagnosis and treatment of immune-mediated chronic hepatitis in dogs lead to a generally good to excellent prognosis.
- Proactive management is essential to mitigate disease progression and optimize patient outcomes.
- Ongoing research into novel therapeutic approaches may further improve long-term management of canine hepatitis.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
536
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
536
01:24Chronic Pancreatitis I: Introduction
147
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
147
01:29Chronic Pancreatitis II: Collaborative Care
127
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
127
01:25Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264